These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 12759327)

  • 1. Composite outcomes in randomized trials: greater precision but with greater uncertainty?
    Freemantle N; Calvert M; Wood J; Eastaugh J; Griffin C
    JAMA; 2003 May; 289(19):2554-9. PubMed ID: 12759327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials.
    Shaikh A; Ochani RK; Khan MS; Riaz H; Khan SU; Sreenivasan J; Mookadam F; Doukky R; Butler J; Michos ED; Kalra A; Krasuski RA
    Am Heart J; 2020 Dec; 230():71-81. PubMed ID: 32941789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composite outcomes in cardiovascular research: a survey of randomized trials.
    Lim E; Brown A; Helmy A; Mussa S; Altman DG
    Ann Intern Med; 2008 Nov; 149(9):612-7. PubMed ID: 18981486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials.
    Ferreira-González I; Busse JW; Heels-Ansdell D; Montori VM; Akl EA; Bryant DM; Alonso-Coello P; Alonso J; Worster A; Upadhye S; Jaeschke R; Schünemann HJ; Permanyer-Miralda G; Pacheco-Huergo V; Domingo-Salvany A; Wu P; Mills EJ; Guyatt GH
    BMJ; 2007 Apr; 334(7597):786. PubMed ID: 17403713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal Trends in Use of Composite End Points in Major Cardiovascular Randomized Clinical Trials in Prominent Medical Journals.
    Tan NS; Ali SH; Lebovic G; Mamdani M; Laupacis A; Yan AT
    Circ Cardiovasc Qual Outcomes; 2017 Oct; 10(10):. PubMed ID: 28954803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key issues in end point selection for heart failure trials: composite end points.
    Neaton JD; Gray G; Zuckerman BD; Konstam MA
    J Card Fail; 2005 Oct; 11(8):567-75. PubMed ID: 16230258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals.
    Wood AM; White IR; Thompson SG
    Clin Trials; 2004; 1(4):368-76. PubMed ID: 16279275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reporting adverse events in randomized controlled trials.
    Nuovo J; Sather C
    Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):349-51. PubMed ID: 16998947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Composite outcomes in randomized clinical trials: arguments for and against.
    Ross S
    Am J Obstet Gynecol; 2007 Feb; 196(2):119.e1-6. PubMed ID: 17306647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Composite outcomes in clinical trials: uses and problems.
    Carneiro AV
    Rev Port Cardiol; 2003 Oct; 22(10):1253-63. PubMed ID: 14708338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do we measure the right end points? A systematic review of primary outcomes in recent neonatal randomized clinical trials.
    Zhang B; Schmidt B
    J Pediatr; 2001 Jan; 138(1):76-80. PubMed ID: 11148516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review.
    Cordoba G; Schwartz L; Woloshin S; Bae H; Gøtzsche PC
    BMJ; 2010 Aug; 341():c3920. PubMed ID: 20719825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Informed choice of composite end points in cardiovascular trials.
    Gómez G; Gómez-Mateu M; Dafni U
    Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):170-8. PubMed ID: 24425702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology.
    Raghav KP; Mahajan S; Yao JC; Hobbs BP; Berry DA; Pentz RD; Tam A; Hong WK; Ellis LM; Abbruzzese J; Overman MJ
    J Clin Oncol; 2015 Nov; 33(31):3583-90. PubMed ID: 26304898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use and interpretation of composite end points in orthopaedic trials.
    Busse JW; Bhandari M; Ferreira-González I; Montori VM; Guyatt GH
    J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():65-9. PubMed ID: 22810451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of epidural injections for spinal stenosis published in the New England Journal of Medicine: further confusion without clarification.
    Manchikanti L; Candido KD; Kaye AD; Boswell MV; Benyamin RM; Falco FJ; Gharibo CG; Hirsch JA
    Pain Physician; 2014; 17(4):E475-88. PubMed ID: 25054398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival end point reporting in randomized cancer clinical trials: a review of major journals.
    Mathoulin-Pelissier S; Gourgou-Bourgade S; Bonnetain F; Kramar A
    J Clin Oncol; 2008 Aug; 26(22):3721-6. PubMed ID: 18669458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Registered and Published Primary Outcomes in Randomized Controlled Trials of Orthopaedic Surgical Interventions.
    Rongen JJ; Hannink G
    J Bone Joint Surg Am; 2016 Mar; 98(5):403-9. PubMed ID: 26935463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of registered and published primary outcomes in randomized clinical trials of surgical interventions.
    Hannink G; Gooszen HG; Rovers MM
    Ann Surg; 2013 May; 257(5):818-23. PubMed ID: 23407296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of the results of clinical trials: surrogate end points and composite end points.
    Gensini GF; Conti AA
    Minerva Med; 2004 Feb; 95(1):71-5. PubMed ID: 15041928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.